Fig. 2.
Structure of mature rhGAA. a Proteolytic treatment of rhGAA. b Schematic representation of the sequence of GAA. Myozyme® rhGAA used in ERT starts at residue Q57. Domains corresponding to the rhGAA structure are colored as in c, with the regions removed by treatment with α-chymotrypsin colored in white. c Cartoon representation of the structure of rhGAA consisting of the trefoil type-P domain (salmon), the N-terminal β-sheet domain (slate), the catalytic GH31 (β/α)8 barrel domain (green) with insert I (gold) and insert II (pink), and the proximal (orange) and distal (teal) β-sheet domains. Catalytic residues (magenta) and glycan chains (grey) are depicted as sticks. Dashed lined circles highlight peptide portions removed by proteolysis with α-chymotrypsin before crystallization. (SP, signal peptide; PP, propeptide)